Diagnostic role of serum interleukin-18 in gastric cancer patients

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 28

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

313

HTML

2613

Figures (1-4)

207

Tables (1-1)

209

Sum=3342

Jul 28, 2006 (publication date) through Nov 14, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Gastric Cancer

World J Gastroenterol. Jul 28, 2006; 12(28): 4473-4477
Published online Jul 28, 2006. doi: 10.3748/wjg.v12.i28.4473

Figure 1 Symptoms of gastric cancer patients.

Open in New Tab Full Size Figure Download Figure

Figure 2 Mean survival time of gastric cancer patients.

Figure 3 IL-18 levels in gastric cancer patients compared with gastric ulcer patients.

Figure 4 IL-6 levels in gastric cancer with distant metastasis compared to those with no metastasis.

Citation: Thong-Ngam D, Tangkijvanich P, Lerknimitr R, Mahachai V, Theamboonlers A, Poovorawan Y. Diagnostic role of serum interleukin-18 in gastric cancer patients. World J Gastroenterol 2006; 12(28): 4473-4477
URL: https://www.wjgnet.com/1007-9327/full/v12/i28/4473.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i28.4473